abstract |
The invention relates to benylalcohol phospholipase A2 inhibitors, pharmaceutical compositions containing them, and methods of treating phospholipase A2-mediated conditions in mammals by administration of a therapeutically effective amount of such a benzylalcohol phospholipase A2 inhibitor. |